Peer Review History
| Original SubmissionNovember 22, 2025 |
|---|
|
Dear Dr. sharyan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 10 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mohammed Zawiah Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information . 4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Dear reviwers thank you for your effort in conducting this study, it's interesting, here are some minor comments - Did you conduct a pilot study? - what are the practical implication of your study - Language and gramatical revision are needed Reviewer #2: I recommend the manuscript be revised to address these fundamental issues regarding conceptual clarity, methodological transparency, and internal consistency. The study has valuable data, and these revisions will ensure its message is communicated with precision and rigor Title • The title requires revision for scientific precision. The term (Uncovering) is stylistic rather than scientific and implies discovery or novelty, which is not necessary here. Replacing it would improve neutrality and clarity. • More importantly, the title refers to (Eating Disorders), which may imply clinically diagnosed conditions. However, the study assesses risk of disordered eating using the EAT-26, not diagnosed eating disorders. • Please standardize terminology based on your outcome (EAT-26 ≥20) from the introduction through the conclusion. I recommend using "disordered eating risk" or "risk of disordered eating behaviors" consistently. Abstract • The Results section does not clearly report sociodemographic, lifestyle, and health-related characteristics, although these are mentioned. • Protective factors are reported in the Results but are not reflected in the title or study objective; this inconsistency should be addressed. • The Conclusion uses the terms “disordered eating behaviors” and “at risk based on EAT-26,” which aligns with the methods but conflicts with the title’s reference to “eating disorders.” Terminology should be consistent throughout. • Please revise some sentences for clarity and professional flow. Introduction • The objective is generally reflected in the title through terms such as “burden” and “risk factors.” However, for accuracy, the title should explicitly indicate risk of disordered eating rather than diagnosed eating disorders. Methods Terminology • The manuscript uses multiple terms interchangeably (eating disorders, disordered eating, disordered eating behaviors), despite using the EAT-26, which measures risk of disordered eating. Please standardize terminology throughout according to the measurement tool. Study Setting and Participants • Please clarify: o The method used to select institutions and participants. o The names of universities and cities included to support claims of broad geographical representation. o Whether all institutions were located in Sana’a or across different regions in Yemen. • There is inconsistency between “universities in Yemen” (Abstract) and “institutions” (Methods). Please unify terminology. Sample Size • The use of G*Power for sample size calculation should be supported by: o Justification for selecting this method. o Relevant parameters and references. Inclusion and Exclusion Criteria • There is repetition in the presentation of inclusion criteria; please streamline. • Exclusion criteria are not reported and should be clearly stated. • The criterion “age ≥18 years” adds limited value, as undergraduate medical students are typically adults; please justify its inclusion. • Clarify how voluntary participation and electronic informed consent were obtained and documented. Instruments o Before detailing sections, introduce the overall questionnaire used in the study. State clearly of this subsection that a structured, self-administered online questionnaire was used? • Regarding the EAT-26: o Specify whether a free or licensed version was used and whether formal permission was obtained. o Please attach the questionnaire and EAT-26 tool you have used. o Provide details on validation, including reliability, internal consistency, and any face or content validation performed. o Clarify whether the Arabic and/or English versions were used. o The phrase (previously validated versions) requires clarification and supporting references. o Please discuss whether these validated versions are appropriate for Yemeni medical students. Study Design • Specify whether the study was conducted electronically, face-to-face, or both. • Clarify whether the questionnaire was self-administered. Statistical Analysis • The overall statistical plan is appropriate; however, additional details are required to confirm rigor: • Report the number of participants with EAT-26 ≥20 and whether the events-per-variable criterion was satisfied for logistic regression. • Indicate whether multicollinearity and model fit diagnostics were assessed. • Clarify whether continuous predictors were modeled as continuous or categorical, and whether linearity was assessed. • The use of the Kolmogorov–Smirnov test should be clarified. Since normality is not an assumption of logistic regression, please explain that it was used to guide data presentation (mean ± SD vs. median [IQR]). • Specify the variable selection method used in the final regression model (e.g., enter, stepwise). • Please justify the use of p < 0.20 for variable selection in the multivariable logistic regression and provide the corresponding bivariate analysis results, as they are not included in the manuscript. Results • The Results section should begin with a brief descriptive summary of participant demographics. • The prevalence of disordered eating is not clearly explained. Although referenced in Table 1, it does not appear to be calculated there—please clarify. • Results consistently describe “risk of disordered eating”, not eating disorders, which conflicts with the title. • Some variables in Table 1 (e.g., academic year, marital status) appear inconsistently interpreted; please recheck and align text with tables. • Table 3: The title and text should be consistent (behavioral attitudes vs. disordered eating behaviors). Percentages should be carefully reviewed. • Please check and correct the percentage totals in your tables, as some appear to sum to 100.1% or 99.9%. • Table 4: o Ensure consistency between the table title and the text description. o Clarify the rationale for reporting two p-value thresholds (p <0.05; *p <0.001). o In the Methods, you state that students were classified into two groups based on EAT-26, but this classification is not clearly presented in the tables. o Add abbreviations and footnotes for clarity. o Explain why certain significant sociodemographic predictors were not included in the final model. Discussion • There is an inconsistency regarding marital status: it is reported as non-significant in the Discussion, yet Table 1 shows a significant association (p <0.001). • The statement (Our study reinforces that medical trainees consistently exhibit higher disordered eating prevalence than the general population (10.4% vs. 5.7%) in females, particularly within non-Western cultures (28,31), is not clearly supported by the study’s own data; please clarify or remove. • The statement (Our finding that 30.4% of medical trainees screened positive for disordered eating exceeds the global pooled prevalence estimates..), please specify whether the Prevalence calculation and screening tools used in these global studies are comparable to those used in the present study? Conclusion • The Conclusion should focus strictly on key findings. Limitations and strengths are better placed in a dedicated section or at the end of the Discussion. • No need to mention and repeat the percentage in the conclusion. Acknowledgments • The Acknowledgments section is overly long and should be shortened. References • Some references require updating (e.g., references 21 and 25). Based on the detailed comments in the provided PDF, please revise the manuscript to address all remaining issues identified therein. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 1 |
|
Dear Dr. sharyan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: The manuscript addresses an important topic and has a valuable national multicenter scope; however, several issues require clarification to improve rigor, consistency, and alignment of conclusions with the cross-sectional design. Furthermore, please address the comments highlighted below from Reviewer 2. Abstract: Please address internal consistency and reporting clarity. The proportion reporting a prior eating disorder diagnosis (31.6%) appears unusually high and exceeds the EAT-26 positive screening proportion (30.4%); clarify how “prior diagnosis” was defined/ascertained (self-report vs. verified) and ensure it is plausible and interpretable. Methods: The recruitment is described as “official student communication platforms,” but there is no clear sampling method (probability vs convenience), no denominator (how many students were invited/eligible across the 15 colleges), and no response rate. This is critical for a national multicenter online survey and should be added. Selecting variables by bivariate p < 0.20 can be acceptable, but please justify and consider including a priori confounders regardless of p-value. “descriptive cross-sectional study with an analytical component” is redundant; you can simply state “national multicenter cross-sectional study.” You mention Arabic/English EAT-26 versions are validated, but please cite the specific validation studies used and clarify whether you used official translations. Height/weight are “self-reported”. Please acknowledge potential measurement bias and specify whether BMI was calculated and how missing/implausible values were handled. Results: The prevalence of “previous eating disorder diagnosis” (31.6%) appears unusually high and exceeds the EAT-26 positive screening prevalence (30.4%); please clarify how prior diagnosis was defined/ascertained (self-report vs verified) and ensure consistency. There is also an apparent denominator/label mismatch where n=1,117 is used both for “prior diagnosis” and later for “disordered eating symptoms,” suggesting a reporting error. You report multiple diagnoses (PTSD, OCD, bipolar, schizophrenia, etc.) as “self-reported.” In Results, these are treated as clinical diagnoses, but if they are self-reported, interpretation changes substantially. Also, the prevalence of some diagnoses in a student sample may be questioned. Please state explicitly whether psychiatric conditions were self-reported diagnoses vs screened using validated instruments, and consider presenting them as “self-reported history of…” to avoid implying clinical confirmation. You list behaviors like vomiting/laxatives/diet pills with high prevalence in the full sample. That’s important epidemiologically, but ensure it is framed descriptively and not as normalized; also ensure the denominator (lifetime vs recent) is clear. Please specify the time frame for each behavior (lifetime vs past 28 days/3 months), and ensure wording is clinically neutral and precise. Conclusion The conclusion is overly long and expansive and reads partly like a second Results/Discussion section. Please condense it to the key prevalence finding and a brief summary of the main associated domains, and avoid overstatement (e.g., replace “demonstrates”/“complex interplay” with more cautious wording consistent with a cross-sectional screening study). In addition, temper the implementation recommendations (screening/support services) so they are framed as considerations rather than implied effects, and ensure the novelty claim (“first national evidence”) is clearly justified by the literature review. ============================== Please submit your revised manuscript by Apr 08 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mohammed Zawiah Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes ********** Reviewer #2: Reviewer Comments: Results-Table 1: • The statement about sixth-year students is incorrect. First-year students are the clear high-risk group (23.2% vs. 14.7%). Please Revise. • Improve reporting: please Replace "higher proportions were observed" with explicit comparisons (e.g., "16.4% vs. 5.1%"). • Highlight key findings: Emphasize the strongest associations (suicide attempts, autism, diabetes) showing >3x higher prevalence. • It's better to add (* or Bold) to indicate the significance. Results-Figure 1: • The text incorrectly uses the statistical term "no significant weight." Figure 1 is descriptive and shows no p-values. Correct to descriptive language like "no weight change" or "stable weight," matching the figure's legend. Results – Table 2: • The Results should include comparative percentages to show magnitude (e.g., PTSD 8.3% vs. 3.0%). • Phrases like “exhibited higher proportions” should be replaced with precise wording reflecting screening positive for disordered eating risk. • Highlight strong associations, such as bipolar disorder (3.6% vs. 0.6%) and schizophrenia (3.0% vs. 0.4%), which are 6–7 times higher in the risk group. • “All assessed psychiatric conditions, with the exception of obsessive traits, were significantly associated…” borderline personality disorder was NOT significant, so this sentence is inaccurate. • Add abbreviation on table footnote: e.g. PTSD, OCD,… Results- Table 4: • The total for "Eating binges" (n=3707) exceeds the sample size (N=3540), causing an impossible percentage (104.9%). • Recalculate all frequencies so that Yes + No = 3540 (100%) for each behavior. Discussion: • A contradiction exists regarding marital status: The Discussion states: "variables such as marital status ... were not independently associated with disordered eating risk." However, Table 1 shows marital status was significantly associated in bivariate analysis (p<0.001). • Please correct the Discussion to accurately reflect that while marital status showed a significant bivariate association, it was not retained as an independent predictor in the final multivariate model. The current wording is misleading. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: Yes: Dr. Mohammed M. Battah, PhD, Clinical Pharmacy, University of Science and Technology, Sana'a, Yemen ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Prevalence and risk factors of disordered eating risk among Yemeni medical students: a national multicenter cross-sectional study PONE-D-25-61542R2 Dear Dr. sharyan, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mohammed Zawiah Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-61542R2 PLOS One Dear Dr. sharyan, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mohammed Zawiah Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .